Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
Status:
Active, not recruiting
Trial end date:
2024-11-20
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if vorinostat when given with
isotretinoin and temozolomide can help to control glioblastoma or gliosarcoma. The safety of
these drug combinations will also be studied.